Brief: Regenxbio says Sarepta To Pay $39 Million To Regenxbio Within 10 Days Of Effective Date
23/09/2026 22:09
BRIEF-Regenxbio says Sarepta To Pay $39 Million To Regenxbio Within 10 Days Of Effective Date Sept 24 (Reuters) - REGENXBIO Inc. RGNX.O:
REGENXBIO - SAREPTA TO PAY $39 MILLION TO REGENXBIO WITHIN 10 DAYS OF EFFECTIVE DATE - SEC FILING
REGENXBIO - ALL ONGOING PATENT LITIGATION REGARDING PATENTS-IN-SUIT TO BE TERMINATED WITH PREJUDICE - SEC FILING
REGENXBIO - AGREES NOT TO SUE SAREPTA OR AFFILIATES OVER EXISTING ELEVIDYS OR AAVRH74-BASED CAPSIDS - SEC FILING
REGENXBIO INC: CO AND TRUSTEES OF UNIVERSITY OF PENNSYLVANIA ENTERED INTO SETTLEMENT AGREEMENT WITH SAREPTA THERAPEUTICS INC
Further company coverage: RGNX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on REGENXBIO
See all newsBrief: Regenxbio says Sarepta To Pay $39 Million To Regenxbio Within 10 Days Of Effective Date
Regenxbio climbs as new director buys nearly $1 million of stock
Brief: Regenxbio Strengthens Board Of Directors With Appointment Of Greg Ciongoli
U.S. STOCKS ON THE MOVE-Strategy, Ecovyst, Azenta
U.S. STOCKS ON THE MOVE-Azenta, Qiagen NV, Capricor Therapeutics